Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.53 |
| ▸ | LTA4H | P09960 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | CASP1 | P29466 | 2/20 | 0.46 |
| ▸ | CASP7 | P55210 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7594347 | 0.98 | LTA4H (0.52) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL14703073 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL13942801 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL13707359 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| Alpha-Terthienyl SCHEMBL147274 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL23611278 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL2742433 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL13707354 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL1105086 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL499333 | 0.86 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2762514-B1 | COMPOSITION HAVING CHANGEABLE SOLUBILITY, HOLE TRANSPORT MATERIAL COMPOSITION, AND ORGANIC ELECTRONIC ELEMENT PRODUCED USING EACH OF SAID COMPOSITIONS | SHOWA DENKO MATERIALS CO LTD (JP) | 2021-03-17 | — | — | EP | disclosed |
| EP-2379109-B1 | COMBINATION OF PHOTODYNAMIC THERAPY AND ANTI-VEGF AGENTS IN THE TREATMENT OF UNWANTED CHOROIDAL NEOVASCULATURE | BAUSCH HEALTH COMPANIES INC (CA) | 2020-10-07 | — | — | EP | disclosed |
| US-9263683-B2 | Use of cobalt complexes for preparing an active layer in a photovoltaic cell, and corresponding photovoltaic cell | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-02-16 | — | — | US | disclosed |
| US-9226917-B2 | Photodynamic therapy for conditions of the eye | VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 2016-01-05 | — | — | US | disclosed |
| US-9147848-B2 | Low bandgap dicyanovinyl and tricyanovinyl oligothiophenes for solar cell applications | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-09-29 | — | — | US | disclosed |
| US-20150141664-A1 | LOW BANDGAP DICYANOVINYL AND TRICYANOVINYL OLIGOTHIOPHENES FOR SOLAR CELL APPLICATIONS | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-05-21 | — | — | US | disclosed |
| EP-2691404-B1 | USE OF COBALT COMPLEXES FOR THE PREPARATION OF THE ACTIVE LAYER OF A PHOTVOLTAIC CELL, AND CORRESPONDING PHOTOVOLTAIC CELL | CENTRE NAT RECH SCIENT (FR) | 2015-05-06 | — | — | EP | disclosed |
| EP-2691404-B1 | USE OF COBALT COMPLEXES FOR THE PREPARATION OF THE ACTIVE LAYER OF A PHOTVOLTAIC CELL, AND CORRESPONDING PHOTOVOLTAIC CELL | CENTRE NAT RECH SCIENT (FR) | 2015-05-06 | — | — | EP | disclosed |
| US-8975419-B2 | Low bandgap dicyanovinyl and tricyanovinyl oligothiophenes for solar cell applications | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2015-03-10 | — | — | US | disclosed |
| US-8968715-B2 | Drug delivery systems for photodynamic therapy | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2015-03-03 | — | — | US | disclosed |
| US-20020061330-A1 | Supports for photosensitizer formulations | BRITISH COLUMBIA, THE UNIVERSITY OF (CA) | 2002-05-23 | — | — | US | disclosed |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | QLT INC. (CA) | 2002-02-21 | — | — | US | disclosed |
| WO-2001085213-A2 | SUPPORTS FOR PHOTOSENSITIZER FORMULATIONS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001085212-A2 | DRUG DELIVERY SYSTEMS FOR PHOTODYNAMIC THERAPY | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001035996-A2 | USE OF PDT TO INHIBIT INTIMAL HYPERPLASIA | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001035997-A2 | USE OF LOW-DOSE PDT TO INHIBIT RESTENOSIS | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| US-5753692-A | PLANT EXTRACTS, IMMUNOSTIMULANTS TREATING IMMUNODEFICIENCY DISEASES | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1998-05-19 | — | — | US | disclosed |
| US-5747525-A | ANTITUMOR AGENTS OF OLIGOMERS OF THIOPHENE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1998-05-05 | — | — | US | disclosed |
| US-5602170-A | ADMINISTERING ANTIIFLAMMATORY AGENT | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1997-02-11 | — | — | US | disclosed |
| US-5045563-A | Terthienyl Compound | HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRESENTED BY MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 1991-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141664-A1 | LOW BANDGAP DICYANOVINYL AND TRICYANOVINYL OLIGOTHIOPHENES FOR SOLAR CELL APPLICATIONS | DSG1, CDC73, CDC23 | DPP4 1416/4885LTA4H 3894/4885ALDH1A1 3139/4885 |
| US-20020061330-A1 | Supports for photosensitizer formulations | PPOX, PPIF, SDHA | DPP4 2865/4885LTA4H 1099/4885ALDH1A1 371/4885 |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | CD74, ANXA11, ANXA1 | DPP4 1489/4885LTA4H 846/4885ALDH1A1 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.